Area 1. Pathophysiological and molecular mechanisms underlying decompensated cirrhosis and its complications (ascites, renal failure, bacterial infections, hepatic encephalopathy) and acute on chronic liver failure.
Area 2. Epidemiology, clinical features and prognosis of decompensated cirrhosis and its complications (ascites, renal failure, bacterial infections, hepatic encephalopathy, sarcopenia) and acute on chronic liver failure in patients waiting or not for liver transplantation.
Area 3. Non-oncotic properties of the human albumin molecule and therapeutic role of human albumin administration in patients with decompensated cirrhosis waiting or not for liver transplantation.
Area 4. Novel pharmacological approaches in the management of patients with chronic liver failure and acute on chronic liver failure waiting or not for liver transplantation.
